The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Net Asset Value

26 Mar 2020 17:25

RNS Number : 7826H
Maven Income and Growth VCT 5 PLC
26 March 2020
 

 

Maven Income and Growth VCT 5 PLC

 

 

Update on Net Asset Value

The Board of Maven Income and Growth VCT 5 PLC (the Company) announces that, as at 20 March 2020, the unaudited net asset value (NAV) of the Company was 33.99p per share.

The NAV as at 20 March 2020 is unaudited and reflects the closing bid price of quoted securities as at that date. Investments in unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 30 November 2019, adjusted for subsequent events where appropriate.

 

The rapidly evolving situation around the impact of the COVID-19 pandemic, including measures announced by business and government, has resulted in a period of considerable uncertainty for all UK businesses and global financial markets. Where possible, Maven is working closely with the management team of every investee company and the Board to assess the likely impact across the portfolio. However, at this stage, the Board has considered it prudent to apply a provision to the valuations of certain investments principally in those sectors which are consumer facing and which will be most immediately affected by the current situation.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via a Regulatory Information Service this inside information is now considered to be in the public domain.

 

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Company Secretary

26 March 2020

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVKKABDOBKDFNB
Date   Source Headline
5th Nov 20144:20 pmRNSTransaction in Own Shares
4th Nov 201411:46 amRNSTransaction in Own Shares
3rd Nov 20143:59 pmRNSTransaction in Own Shares
20th Oct 20146:27 pmRNSStatement re Prospectus and Circular
9th Oct 201412:30 pmRNSInterim Management Statement
3rd Oct 20144:27 pmRNSTotal Voting Rights
1st Oct 201410:50 amRNSStatement re Joint Offer for Subscription
21st Aug 20141:09 pmRNSTransaction in Own Shares
14th Aug 20145:07 pmRNSTransaction in Own Shares
13th Aug 201412:27 pmRNSTransaction in Own Shares
12th Aug 20142:38 pmRNSTransaction in Own Shares
11th Aug 20144:08 pmRNSTransaction in Own Shares
5th Aug 201411:36 amRNSReplacement Director/PDMR Shareholding
1st Aug 20143:23 pmRNSDirector/PDMR Shareholding
1st Aug 20143:20 pmRNSDirector/PDMR Shareholding
1st Aug 20143:19 pmRNSDirector/PDMR Shareholding
30th Jul 201411:12 amRNSHalf Yearly Report
4th Jul 20144:34 pmRNSReplacement re Issue of Equity
3rd Jul 20144:23 pmRNSDirector/PDMR Shareholding
2nd Jul 20149:51 amRNSIssue of Equity
28th May 20145:13 pmRNSOffer for Subscription Update
27th May 201410:35 amRNSDirector Declaration
30th Apr 20147:01 amRNSStatement re Offer for Subscription
24th Apr 20142:52 pmRNSOffer for Subscription - Supplementary Prospectus
22nd Apr 20143:00 pmRNSResult of AGM
22nd Apr 20142:58 pmRNSDirectorate Change
17th Apr 20143:57 pmRNSInterim Management Statement
16th Apr 201411:49 amRNSDirector Declaration
7th Apr 20144:19 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 201411:32 amRNSIssue of Equity
18th Mar 20147:00 amRNSOffer for Subscription - Supplementary Prospectus
3rd Mar 20144:13 pmRNSAnnual Financial Report
13th Feb 201410:57 amRNSDirector/PDMR Shareholding
13th Feb 201410:55 amRNSDirector/PDMR Shareholding
13th Feb 201410:47 amRNSDirector/PDMR Shareholding
10th Feb 20146:04 pmRNSOffer for Subscription - Supplementary Prospectus
5th Feb 20144:22 pmRNSIssue of Equity
3rd Feb 20145:23 pmRNSStatement re NAV and Offer for Subscription (Repla
27th Jan 20145:00 pmRNSStatement re NAV, Dividend and Offer
27th Nov 20132:07 pmRNSResult of General Meeting
24th Oct 20136:09 pmRNSOffer for Subscription
15th Oct 20135:10 pmRNSTransaction in Own Shares
11th Oct 20135:12 pmRNSInterim Management Statement
11th Oct 201312:18 pmRNSDirectorate Change
10th Oct 201311:02 amRNSNet Asset Value(s)
9th Oct 201311:09 amRNSNet Asset Value(s)
8th Oct 20131:49 pmRNSNet Asset Value(s)
7th Oct 201312:35 pmRNSNet Asset Value(s)
4th Oct 20132:12 pmRNSNet Asset Value(s)
3rd Oct 20132:36 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.